Results 121 to 130 of about 3,965 (158)
Bleeding risk and safety profile related to the use of eptifibatide: a current review
Expert Opinion on Drug Safety, 2012 INTRODUCTION: Eptifibatide is a glycoprotein IIb/IIIa inhibitor that blocks the final common pathway of platelet aggregation. Its major adverse effect is bleeding. Balancing its safety and efficacy is paramount for its appropriate usage.
Fadi Saab
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches: